- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04791306
Impact of 4 Months of Exercise Changes of Heart Health-related Epigenetic Markers in Healthy, Sedentary Individuals (miR-4-heart)
Impact of a 4 Months Training Intervention on Exercise-induced Changes of Heart Health-related Epigenetic Markers in Healthy, Sedentary Individuals
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Exercise induced changes in heat health related miRNA expression pattern are analyzed in plasma samples collected at rest and immediately after the completion of an all-out ergo spirometry test, conducted during the baseline examination. Additionally participants will perform a pulse wave analysis to evaluate their arterial stiffness, a bioimpedanzanalysis to evaluate their body composition, blood lipids will be measured as well as their exercise capacity.
After the baseline examination, all participants will perform once per week a supervised endurance and strength training at our facility. In addition, the participants will be provided with a digital application for planning and documentation of their home based physical activity. Together with an expert, they plan their weekly physical activities so that they reach 150 min of physical activity each week over a period of 4 months.
After this training/exercise intervention all participants will perform all measurements from the baseline examination again.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Salzburg, Austria, 5020
- Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- <150min physical activity per week
- >18 years of age
- male and female
- signed inform consents
Exclusion Criteria:
- acute or chronic cardiovascular diseases, exempt arterial hypertension (systolic blood pressure >140 mmHg and diastolic blood pressure >90 mmHg in untreated and medical treated subjects)
- acute or chronic lung disease
- Alcohol (>30g/day) or drug abuse
- Adipositas grad 2 (BMI >35kg/m²)
- Orthopedic limitations to exercise capacity
- pregnant or breast feeding women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise Training
All participants should increase their physical activity level to at least 150 min per week, guided with once a week supervised in-house training as well as an application for planning and documentation for home-based physical activity
|
Participates perform once a week for 4 months an in-house supervised endurance and strength training.
Participants are provided with an application for planning and documentation of their physical activity, together with an expert participants plan their physical activities for their home-based training to reach at least 150 min physical activity per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
miRNA expression response to acute all-out exercise (ergometry)
Time Frame: Baseline
|
expression change of miRNA due to all-out ergometry at baseline
|
Baseline
|
Change from baseline miRNA expression at 4 months
Time Frame: after 4 months of exercise intervention
|
4 months of exercise intervention in healthy previously sedentary participants leads to exercise-induced changes in the cardio protective miRNA expression profiles
|
after 4 months of exercise intervention
|
Change from baseline in miRNA expression response to acute all-out exercise (ergometry) at 4 months
Time Frame: after 4 months of exercise intervention
|
4 months of exercise intervention in healthy previously sedentary participants leads to a change in the acute exercise response (all-out ergometry).
|
after 4 months of exercise intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate
Time Frame: Before and after 4 months of exercise intervention
|
Heart rate will be measured by graded exercise testing on cycle ergometer.
|
Before and after 4 months of exercise intervention
|
blood lipides
Time Frame: Before and after 4 months of exercise intervention
|
blood lipides will be measured before and after intervention
|
Before and after 4 months of exercise intervention
|
arterial stiffness
Time Frame: Before and after 4 months of exercise intervention
|
arterial stiffness will be measured before and after intervention
|
Before and after 4 months of exercise intervention
|
body composition
Time Frame: Before and after 4 months of exercise intervention
|
body composition will be measured before and after intervention
|
Before and after 4 months of exercise intervention
|
exercise capacity
Time Frame: Before and after 4 months of exercise intervention
|
exercise capacity will be measured by graded exercise testing on cycle ergometer.
|
Before and after 4 months of exercise intervention
|
body weight
Time Frame: Before and after 4 months of exercise intervention
|
body weight will be measured before and after intervention
|
Before and after 4 months of exercise intervention
|
digital application
Time Frame: 4 months of exercise intervention
|
user feedback and user experience will be evaluated after the intervention
|
4 months of exercise intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Prof. Josef Niebauer, MD PhD MBA, Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UISM-13
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sedentary Behavior
-
Research on Healthcare Performance Lab U1290RecruitingSedentary Behavior | Sedentary Time | Health Behavior | Health-Related Behavior | Physical InactivityFrance
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSedentary Behavior | Sedentary TimeUnited States
-
Loughborough UniversityBritish Heart FoundationCompletedSedentary Lifestyle | Sedentary Behavior | Diet Habit
-
Biruni UniversityCompletedSedentary Behavior | Health BehaviorTurkey
-
Eskisehir Technical UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruitingSedentary Lifestyle | Sedentary Behavior | Physical Activity Level
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
The University of Texas Health Science Center,...M.D. Anderson Cancer CenterRecruitingSedentary BehaviorUnited States
-
School of Health Sciences GenevaRecruiting
-
Universita di VeronaNot yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulNot yet recruitingSedentary BehaviorBrazil
Clinical Trials on supervised exercise training
-
University of ManchesterUnknownCardiovascular Diseases | Peripheral Arterial Disease
-
Medical University of ViennaUnknownPeripheral Artery DiseaseAustria
-
Chang Gung Memorial HospitalCompleted
-
University of Central ArkansasCompletedDiabetes Mellitus, Type 2United States
-
Rigshospitalet, DenmarkUnknownIntermittent ClaudicationDenmark
-
Sheffield Teaching Hospitals NHS Foundation TrustSheffield Hallam UniversityCompletedCardiovascular Disease | Aneurysm | Aortic Aneurysm, Abdominal | Vascular Disease | Aortic DiseaseUnited Kingdom
-
University of Colorado, DenverAmerican Diabetes AssociationCompleted
-
Université de SherbrookeCompleted
-
University of VermontCompletedCancer ThrombosisUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure, CongestiveUnited States, Canada, France